Corrigendum: Iguratimod as a New Drug for Rheumatoid Arthritis: Current Landscape

Frontiers in Pharmacology - Switzerland
doi 10.3389/fphar.2020.00488
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Frontiers Media SA

Related search

Drug Utilization Patterns for Rheumatoid Arthritis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

MicroRNAs as New Player in Rheumatoid Arthritis

Joint Bone Spine
Rheumatology
2011English

Drug Trials in Rheumatoid Arthritis

InPharma
1980English

Baricitinib: A New Oral Treatment for Rheumatoid Arthritis

Prescriber
Pharmacology
2017English

Rheumatoid Arthritis as a Psychosomatic Disease

Nauchno-Prakticheskaya Revmatologiya
RheumatologyAllergyImmunology
2015English

Rheumatoid Arthritis as a Psychological Disorder

BMJ
1949English

Rheumatoid Arthritis as Infection

BMJ
1970English

Sarilumab: A New IL-6 Receptor Blocker for Rheumatoid Arthritis

Prescriber
Pharmacology
2017English

AB0439 Efficacy at Three Years of Daily Clinical Use of Iguratimod in Patients With Rheumatoid Arthritis

2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy